-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Neuphoria Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2023 to Q4 2024.
- Neuphoria Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$1.94M, a 57.3% increase year-over-year.
- Neuphoria Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$15.5M, a 27.5% increase from 2023.
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)